Pennington, NJ, United States of America

Michael J Hageman


 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael J Hageman: Innovator in Pharmaceutical Compositions

Introduction

Michael J Hageman is a notable inventor based in Pennington, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of bioavailable compositions. With a total of 2 patents, Hageman's work focuses on enhancing the stability and efficacy of pharmaceutical compounds.

Latest Patents

Hageman's latest patents include "Bioavailable compositions of amorphous piperidinyl compounds." This invention relates to solid amorphous dispersions comprising Compound I and one or more polymers. The invention is particularly noteworthy for its unexpectedly stable amorphous solid dispersions that may be used for tabletting. Another significant patent is "Imidazole prodrug LXR modulators." This patent discloses imidazole prodrugs that are useful as modulators of liver X receptors (LXR), along with pharmaceutical compositions and methods of using these compounds.

Career Highlights

Michael J Hageman is currently associated with Bristol-Myers Squibb Company, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug formulations that enhance patient outcomes.

Collaborations

Hageman has collaborated with esteemed colleagues such as Ching-Chiang Su and Rodney D Vickery, further enriching his contributions to the field.

Conclusion

Michael J Hageman's innovative work in pharmaceutical compositions demonstrates his commitment to improving drug efficacy and stability. His patents reflect a deep understanding of complex chemical interactions, making him a valuable asset in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…